PRF Technologies (PRFX) Operating Expenses (2020 - 2024)
PRF Technologies (PRFX) posted quarterly Operating Expenses of -$16.8 million for Q2 2024, down 634.59% year-on-year from $3.1 million in Q3 2023, and down 529.42% on a QoQ basis from $3.9 million in Q1 2024.
PRF Technologies (PRFX) Operating Expenses (2020 - 2024) Analysis & Trends
PRF Technologies (PRFX) has reported Operating Expenses for 5 consecutive years, with -$16.8 million the latest figure, recorded in Q2 2024.
- Quarterly Operating Expenses fell 634.59% year-over-year to -$16.8 million in Q2 2024, while the trailing twelve-month figure through Dec 2025 was -$16.8 million (down 333.29% YoY) and the FY2025 annual result came in at $4.1 million, down 71.74% from the prior year.
- Operating Expenses eased to -$16.8 million in Q2 2024 per PRFX's latest filing, from $3.9 million in the prior quarter.
- Over the last five years, Operating Expenses for PRFX reached as high as $14.5 million in Q4 2022 and fell as low as -$16.8 million in Q2 2024.
- A 5-year average of $802166.7 and a median of -$129000.0 in 2020 frame the typical range for Operating Expenses.
- Annual changes were most pronounced in 2022 — Operating Expenses plunged 1742.11% — and 2023, when it surged 976.88%.
- Year by year, Operating Expenses stood at $2.7 million in 2020, then soared by 375.07% to $12.7 million in 2021, then climbed by 14.26% to $14.5 million in 2022, then tumbled by 37.67% to $9.0 million in 2023, then plunged by 286.45% to -$16.8 million in 2024.
- According to Business Quant data, Operating Expenses over the past three periods registered -$16.8 million, $3.9 million, and $9.0 million for Q2 2024, Q1 2024, and Q4 2023 respectively.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Opex (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 87.22 Bn | 85.35 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 39.60 Bn | 35.87 Bn | 1.97 Bn | 1.00 Bn |
| 3 | Zoetis | 31.46 Bn | 29.52 Bn | 1.62 Bn | 788.00 Mn |
| 4 | Takeda Pharmaceutical | 26.49 Bn | 22.44 Bn | 4.39 Bn | 12.58 Bn |
| 5 | United Therapeutics | 23.03 Bn | 20.88 Bn | 648.10 Mn | 455.70 Mn |
| 6 | Universe Pharmaceuticals | 23.03 Bn | -10.56 Bn | - | - |
| 7 | Viatris | 20.90 Bn | 19.09 Bn | 1.16 Bn | 1.24 Bn |
| 8 | Neurocrine Biosciences | 17.50 Bn | 16.19 Bn | 800.70 Mn | 621.10 Mn |
| 9 | Elanco Animal Health | 12.33 Bn | 11.91 Bn | 785.00 Mn | 494.00 Mn |
| 10 | PRF Technologies | 745,168.93 | 451,168.93 | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2024 | -16.83 Mn |
| Mar 31, 2024 | 3.92 Mn |
| Dec 31, 2023 | 9.03 Mn |
| Sep 30, 2023 | -174,000.00 |
| Jun 30, 2023 | 3.15 Mn |
| Mar 31, 2023 | -2.42 Mn |
| Dec 31, 2022 | 14.48 Mn |
| Sep 30, 2022 | -4.94 Mn |
| Jun 30, 2022 | -359,000.00 |
| Mar 31, 2022 | -312,000.00 |
| Dec 31, 2021 | 12.68 Mn |
| Sep 30, 2021 | -5.23 Mn |
| Jun 30, 2021 | -256,000.00 |
| Mar 31, 2021 | 19,000.00 |
| Dec 31, 2020 | 2.67 Mn |
| Sep 30, 2020 | -830,000.00 |
| Jun 30, 2020 | -66,000.00 |
| Mar 31, 2020 | -84,000.00 |